I agree that this site is using cookies. You can find further informations
here
.
X
Login
My folder (
0
)
Home
About us
Home About us
Our history
Profile
Press & public relations
Friends
The library in figures
Exhibitions
Projects
Training, internships, careers
Films
Services & Information
Home Services & Information
Lending and interlibrary loans
Returns and renewals
Training and library tours
My Account
Library cards
New to the library?
Download Information
Opening hours
Learning spaces
PC, WLAN, copy, scan and print
Catalogs and collections
Home Catalogs and Collections
Rare books and manuscripts
Digital collections
Subject Areas
Our sites
Home Our sites
Central Library
Law Library (Juridicum)
BB Business and Economics (BB11)
BB Physics and Electrical Engineering
TB Engineering and Social Sciences
TB Economics and Nautical Sciences
TB Music
TB Art & Design
TB Bremerhaven
Contact the library
Home Contact the library
Staff Directory
Open access & publishing
Home Open access & publishing
Reference management: Citavi & RefWorks
Publishing documents
Open Access in Bremen
Show Desktop-Version
Toggle navigation
Martín García‐Sancho, Alejandro
172
results:
Search for persons
X
Format
Online (172)
Mediatypes
Articles (Online) (76)
OpenAccess-fulltext (96)
Languages
english (139)
spanish (1)
Sorted by: Relevance
Sorted by: Year
?
1
New therapies for relapsed or refractory aggressive B‐cell ..:
Bastos‐Oreiro, Mariana
;
Abrisqueta, Pau
;
Gutierrez, Antonio
...
HemaSphere. 8 (2024) 4 - p. , 2024
Link:
https://doi.org/10.1002/..
?
2
Phase 2 Trial of the Farnesyltransferase Inhibitor Tipifarn..:
Witzig, Thomas E.
;
Sokol, Lubomir
;
Kim, Won Seog
...
Blood Advances. , 2024
Link:
https://doi.org/10.1182/..
?
3
Peripheral T‐cell lymphoma with a T follicular‐helper pheno..:
Martín García‐Sancho, Alejandro
;
Rodríguez‐Pinilla, Socorro M.
;
Domingo‐Domenech, Eva
...
British Journal of Haematology. 203 (2023) 2 - p. 182-193 , 2023
Link:
https://doi.org/10.1111/..
?
4
Extranodal natural killer/T‐cell lymphoma nasal type in a w..:
Gonzalez Barca, Eva
;
Tomás‐Roca, Laura
;
Esteve, Anna
...
American Journal of Hematology. 98 (2023) 6 - p. , 2023
Link:
https://doi.org/10.1002/..
?
5
Accuracy and prognostic impact of FDG PET/CT and biopsy in ..:
Ródenas‐Quiñonero, Isabel
;
Chen‐Liang, Tzu
;
Martín‐Santos, Taida
...
Cancer Medicine. 12 (2022) 6 - p. 6536-6546 , 2022
Link:
https://doi.org/10.1002/..
?
6
EORTC‐QLQ‐C30 and SKINDEX‐29 measurement of health‐related ..:
Navarro Matilla, Belén
;
Onteniente Gomis, Mª del Mar
;
Pujol Vallverdú, Ramon M.
...
JEADV Clinical Practice. 1 (2022) 4 - p. 438-449 , 2022
Link:
https://doi.org/10.1002/..
?
7
Real‐world evidence of tisagenlecleucel for the treatment o..:
Iacoboni, Gloria
;
Villacampa, Guillermo
;
Martinez‐Cibrian, Nuria
...
Cancer Medicine. 10 (2021) 10 - p. 3214-3223 , 2021
Link:
https://doi.org/10.1002/..
?
8
Cost-Effectiveness Analysis of Axicabtagene Ciloleucel vs. ..:
Martín García-Sancho, Alejandro
;
Presa, María
;
Pardo, Carlos
...
Cancers. 16 (2024) 13 - p. 2301 , 2024
Link:
https://doi.org/10.3390/..
?
9
Lisocabtagene maraleucel in follicular lymphoma: the phase ..:
Morschhauser, Franck
;
Dahiya, Saurabh
;
Palomba, M. Lia
...
Nature Medicine. , 2024
Link:
https://doi.org/10.1038/..
?
10
Author Correction: Lisocabtagene maraleucel in follicular l..:
Morschhauser, Franck
;
Dahiya, Saurabh
;
Palomba, M. Lia
...
Nature Medicine. , 2024
Link:
https://doi.org/10.1038/..
?
11
Impact of the kinetics of circulating anti-CD19 CAR-T cells..:
Martín-Martín, Lourdes
;
Gutiérrez-Herrero, Sara
;
Herrero-García, María
...
Blood Cancer Journal. 14 (2024) 1 - p. , 2024
Link:
https://doi.org/10.1038/..
?
12
18F-FDG-PET/CT response after first-line treatment as a pro..:
Cordoba, Raul
;
Sánchez-García, Joaquín
;
Domingo-Domenech, Eva
...
Expert Review of Hematology. 17 (2024) 1-3 - p. 95-100 , 2024
Link:
https://doi.org/10.1080/..
?
13
CD8+ NKs as a potential biomarker of complete response and ..:
Hontecillas-Prieto, Lourdes
;
García-Domínguez, Daniel J.
;
Palazón-Carrión, Natalia
...
Frontiers in Immunology. 15 (2024) - p. , 2024
Link:
https://doi.org/10.3389/..
?
14
P1080: ZANUBRUTINIB PLUS OBINUTUZUMAB VERSUS OBINUTUZUMAB I..:
Trotman, Judith
;
Luigi Zinzani, Pier
;
Mayer, Jiri
...
HemaSphere. 7 (2023) S3 - p. e2687131 , 2023
Link:
https://doi.org/10.1097/..
?
15
Impact of SCHOLAR-1 Criteria on Chimeric Antigen Receptor T..:
Bastos-Oreiro, Mariana
;
Gutierrez, Antonio
;
Iacoboni, Gloria
...
Transplantation and Cellular Therapy. 29 (2023) 12 - p. 747.e1-747.e10 , 2023
Link:
https://doi.org/10.1016/..
1-15